Published in Mol Pharm on August 03, 2009
Key roles of adjuvants in modern vaccines. Nat Med (2013) 2.62
Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose. Proc Natl Acad Sci U S A (2013) 1.20
Nanoparticle delivery systems in cancer vaccines. Pharm Res (2010) 1.20
Reductively responsive siRNA-conjugated hydrogel nanoparticles for gene silencing. J Am Chem Soc (2012) 1.17
Improvement of different vaccine delivery systems for cancer therapy. Mol Cancer (2011) 1.16
pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides. ACS Nano (2013) 1.13
Membrane anchored immunostimulatory oligonucleotides for in vivo cell modification and localized immunotherapy. Angew Chem Int Ed Engl (2011) 1.04
Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles. Vaccine (2015) 0.85
Adjuvants: Classification, Modus Operandi, and Licensing. J Immunol Res (2016) 0.81
Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases. J R Soc Interface (2013) 0.81
Emerging cancer vaccines: the promise of genetic vectors. Cancers (Basel) (2011) 0.81
The TLR4 agonist fibronectin extra domain A is cryptic, exposed by elastase-2; use in a fibrin matrix cancer vaccine. Sci Rep (2015) 0.80
Tumor lysate-loaded biodegradable microparticles as cancer vaccines. Expert Rev Vaccines (2014) 0.79
Conjugation of lipid and CpG-containing oligonucleotide yields an efficient method for liposome incorporation. Bioconjug Chem (2011) 0.79
Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy. Biomaterials (2016) 0.76
Nanocarrier-based immunotherapy in cancer management and research. Immunotargets Ther (2014) 0.76
Intracellular Cleavable CpG Oligodeoxynucleotide-Antigen Conjugate Enhances Anti-tumor Immunity. Mol Ther (2017) 0.75
Fibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responses. Vaccine (2016) 0.75
Coordinating antigen cytosolic delivery and danger signaling to program potent cross-priming by micelle-based nanovaccine. Cell Discov (2017) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Innate immune recognition. Annu Rev Immunol (2001) 26.65
Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol (2003) 15.65
Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol (2002) 14.75
CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (1995) 12.24
The B7-CD28 superfamily. Nat Rev Immunol (2002) 7.24
T cell anergy. Annu Rev Immunol (2001) 7.15
Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol (2006) 6.00
Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov (2006) 5.19
Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol (2005) 4.30
Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol (2004) 3.82
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol (2007) 3.42
The Toll receptor family and microbial recognition. Trends Microbiol (2000) 3.01
Tumor-specific shared antigenic peptides recognized by human T cells. Immunol Rev (2002) 2.18
A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels. Proc Natl Acad Sci U S A (2003) 2.14
Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat Med (1995) 2.06
Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol (2006) 1.85
A novel strategy for encapsulation and release of proteins: hydrogels and microgels with acid-labile acetal cross-linkers. J Am Chem Soc (2002) 1.57
Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition. J Med Chem (1995) 1.55
TLR9 as a key receptor for the recognition of DNA. Adv Drug Deliv Rev (2008) 1.52
Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications. J Am Chem Soc (2008) 1.39
Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy. Proc Natl Acad Sci U S A (2009) 1.20
In vivo manipulation of dendritic cells to induce therapeutic immunity. Blood (2002) 1.16
Conjugation of ligands at the 5'-end of CpG DNA affects immunostimulatory activity. Bioconjug Chem (2002) 1.11
Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity. Bioconjug Chem (2007) 1.09
Acid-degradable particles for protein-based vaccines: enhanced survival rate for tumor-challenged mice using ovalbumin model. Bioconjug Chem (2004) 1.08
T-cell activation by antigen-loaded pH-sensitive hydrogel particles in vivo: the effect of particle size. Bioconjug Chem (2009) 0.94
Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant. J Immunother (2006) 0.90
Dendritic cells: activation and maturation--applications for cancer immunotherapy. Curr Med Chem (2005) 0.89
Exuberated numbers of tumor-specific T cells result in tumor escape. Cancer Res (2008) 0.89
Antigen-immunostimulatory oligonucleotide conjugates: mechanisms and applications. Immunol Rev (2004) 0.88
Acid-degradable polyurethane particles for protein-based vaccines: biological evaluation and in vitro analysis of particle degradation products. Mol Pharm (2008) 0.84
Extended sequence preferences for oligodeoxyribonucleotide activity. Immunology (2006) 0.84
Microencapsulated subunit vaccine approach to enterotoxigenic Escherichia coli and other mucosal pathogens. Adv Drug Deliv Rev (2005) 0.80
Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet (2006) 15.99
Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol (2002) 7.03
B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med (2011) 5.16
Designing dendrimers for biological applications. Nat Biotechnol (2005) 4.92
Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med (2008) 4.04
Polymer-fullerene composite solar cells. Angew Chem Int Ed Engl (2008) 3.30
Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med (2004) 3.17
A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc Natl Acad Sci U S A (2006) 2.55
Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. Blood (2002) 2.52
Dendrimers and dendritic polymers in drug delivery. Drug Discov Today (2005) 2.37
Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc Chem Res (2009) 2.32
A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels. Proc Natl Acad Sci U S A (2003) 2.14
Efficiency and fidelity in a click-chemistry route to triazole dendrimers by the copper(i)-catalyzed ligation of azides and alkynes. Angew Chem Int Ed Engl (2004) 2.11
Induced immune tolerance for kidney transplantation. N Engl J Med (2011) 2.08
pH-Responsive copolymer assemblies for controlled release of doxorubicin. Bioconjug Chem (2005) 1.98
Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis. Proc Natl Acad Sci U S A (2009) 1.72
Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy. Clin Cancer Res (2006) 1.64
The influence of polymer topology on pharmacokinetics: differences between cyclic and linear PEGylated poly(acrylic acid) comb polymers. J Control Release (2009) 1.62
Isolation of discrete nanoparticle-DNA conjugates for plasmonic applications. Nano Lett (2008) 1.59
Stimuli-responsive supramolecular assemblies of linear-dendritic copolymers. J Am Chem Soc (2004) 1.58
The role of vanin-1 and oxidative stress-related pathways in distinguishing acute and chronic pediatric ITP. Blood (2011) 1.57
A novel strategy for encapsulation and release of proteins: hydrogels and microgels with acid-labile acetal cross-linkers. J Am Chem Soc (2002) 1.57
Osmotic properties of poly(ethylene glycols): quantitative features of brush and bulk scaling laws. Biophys J (2003) 1.54
Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation. Bioconjug Chem (2002) 1.46
Designing macromolecules for therapeutic applications: polyester dendrimer-poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. J Am Chem Soc (2002) 1.45
Dependence of pharmacokinetics and biodistribution on polymer architecture: effect of cyclic versus linear polymers. J Am Chem Soc (2009) 1.44
Induction of potent antitumor immunity by in situ targeting of intratumoral DCs. J Clin Invest (2004) 1.44
Synthesis and properties of star-comb polymers and their doxorubicin conjugates. Bioconjug Chem (2011) 1.42
Synthetic micelle sensitive to IR light via a two-photon process. J Am Chem Soc (2005) 1.41
Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation. J Virol (2002) 1.40
Biological evaluation of polyester dendrimer: poly(ethylene oxide) "bow-tie" hybrids with tunable molecular weight and architecture. Mol Pharm (2005) 1.39
Acetal-derivatized dextran: an acid-responsive biodegradable material for therapeutic applications. J Am Chem Soc (2008) 1.39
Acetals as pH-sensitive linkages for drug delivery. Bioconjug Chem (2004) 1.37
Molecular design and ordering effects in π-functional materials for transistor and solar cell applications. J Am Chem Soc (2011) 1.35
Organic semiconducting oligomers for use in thin film transistors. Chem Rev (2007) 1.34
Biodegradable pH-sensing dendritic nanoprobes for near-infrared fluorescence lifetime and intensity imaging. J Am Chem Soc (2007) 1.30
Monolithic valves for microfluidic chips based on thermoresponsive polymer gels. Electrophoresis (2003) 1.29
Fully acid-degradable biocompatible polyacetal microparticles for drug delivery. Bioconjug Chem (2008) 1.28
Small-molecule-directed nanoparticle assembly towards stimuli-responsive nanocomposites. Nat Mater (2009) 1.28
Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host. Clin Cancer Res (2010) 1.27
High levels of the onco-protein Gfi-1 accelerate T-cell proliferation and inhibit activation induced T-cell death in Jurkat T-cells. Oncogene (2002) 1.26
Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia. Blood (2011) 1.24
PEGylated dendrimers with core functionality for biological applications. Bioconjug Chem (2008) 1.24
Enzymatic microreactor-on-a-chip: protein mapping using trypsin immobilized on porous polymer monoliths molded in channels of microfluidic devices. Anal Chem (2002) 1.23
TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae. Cell Immunol (2007) 1.22
In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles. Proc Natl Acad Sci U S A (2005) 1.22
Exploiting the reversible covalent bonding of boronic acids: recognition, sensing, and assembly. Acc Chem Res (2012) 1.21
Employing end-functional polythiophene to control the morphology of nanocrystal-polymer composites in hybrid solar cells. J Am Chem Soc (2004) 1.20
Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy. Proc Natl Acad Sci U S A (2009) 1.20
Flow control valves for analytical microfluidic chips without mechanical parts based on thermally responsive monolithic polymers. Anal Chem (2003) 1.17
In vivo manipulation of dendritic cells to induce therapeutic immunity. Blood (2002) 1.16
Genome-wide profiles of H2AX and γ-H2AX differentiate endogenous and exogenous DNA damage hotspots in human cells. Nucleic Acids Res (2012) 1.16
Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles. J Control Release (2005) 1.15
Cross-linked microparticles as carriers for the delivery of plasmid DNA for vaccine development. Bioconjug Chem (2004) 1.15
Dendronized linear polymers via "click chemistry". J Am Chem Soc (2004) 1.14
Singlet oxygen generation via two-photon excited FRET. J Am Chem Soc (2004) 1.13
Impact of hydrogel nanoparticle size and functionalization on in vivo behavior for lung imaging and therapeutics. Mol Pharm (2009) 1.12
Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis. Proc Natl Acad Sci U S A (2010) 1.11
Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivity. J Am Chem Soc (2011) 1.11
Chemically programmed cell adhesion with membrane-anchored oligonucleotides. J Am Chem Soc (2011) 1.11
Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines. Nat Chem Biol (2012) 1.10
A biocompatible oxidation-triggered carrier polymer with potential in therapeutics. J Am Chem Soc (2011) 1.09
Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity. Bioconjug Chem (2007) 1.09
A facile and patternable method for the surface modification of carbon nanotube forests using perfluoroarylazides. J Am Chem Soc (2008) 1.09
Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy. Blood (2013) 1.08
Acid-degradable particles for protein-based vaccines: enhanced survival rate for tumor-challenged mice using ovalbumin model. Bioconjug Chem (2004) 1.08
Flk2+ myeloid progenitors are the main source of Langerhans cells. Blood (2005) 1.07
Injection molded microfluidic chips featuring integrated interconnects. Lab Chip (2006) 1.07
Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases. Arterioscler Thromb Vasc Biol (2002) 1.06
Synthetic control of structural order in N-alkylthieno[3,4-c]pyrrole-4,6-dione-based polymers for efficient solar cells. J Am Chem Soc (2010) 1.05
Direct nanoimprinting of metal nanoparticles for nanoscale electronics fabrication. Nano Lett (2007) 1.04
Polyester dendritic systems for drug delivery applications: design, synthesis, and characterization. Bioconjug Chem (2002) 1.04
A direct route to cyclic organic nanostructures via ring-expansion metathesis polymerization of a dendronized macromonomer. J Am Chem Soc (2009) 1.04
Two-photon degradable supramolecular assemblies of linear-dendritic copolymers. Chem Commun (Camb) (2007) 1.03
Clinical utility of the QuantiFERON-TB Gold In-Tube test for the diagnosis of active pulmonary tuberculosis. Scand J Infect Dis (2009) 1.03
Directed antigen presentation using polymeric microparticulate carriers degradable at lysosomal pH for controlled immune responses. Mol Pharm (2005) 1.03
Natural killer cells trigger differentiation of monocytes into dendritic cells. Blood (2007) 1.03
Performance evaluation of the OraQuick hepatitis C virus rapid antibody test. Ann Lab Med (2013) 1.03
A subset of human dendritic cells in the T cell area of mucosa-associated lymphoid tissue with a high potential to produce TNF-alpha. J Immunol (2003) 1.03
An enantioselective fluorescent sensor for sugar acids. J Am Chem Soc (2004) 1.02
Plasmacytoid dendritic cell dichotomy: identification of IFN-α producing cells as a phenotypically and functionally distinct subset. J Immunol (2010) 1.02
Photopatterning enzymes on polymer monoliths in microfluidic devices for steady-state kinetic analysis and spatially separated multi-enzyme reactions. Anal Chem (2007) 1.01
Porous polymer monolithic column with surface-bound gold nanoparticles for the capture and separation of cysteine-containing peptides. Anal Chem (2010) 1.01
Fabrication of porous polymer monoliths covalently attached to the walls of channels in plastic microdevices. Electrophoresis (2003) 1.01
Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates. Mol Pharm (2009) 1.00
Controlling the surface chemistry and chromatographic properties of methacrylate-ester-based monolithic capillary columns via photografting. J Sep Sci (2007) 1.00
Platinum-functionalized random copolymers for use in solution-processible, efficient, near-white organic light-emitting diodes. J Am Chem Soc (2004) 1.00
Dual-function microanalytical device by in situ photolithographic grafting of porous polymer monolith: integrating solid-phase extraction and enzymatic digestion for peptide mass mapping. Anal Chem (2003) 1.00
Enhanced cell penetration of acid-degradable particles functionalized with cell-penetrating peptides. Bioconjug Chem (2008) 1.00
Monitoring the biodegradation of dendritic near-infrared nanoprobes by in vivo fluorescence imaging. Mol Pharm (2009) 1.00